A Multi-component Intervention to Improve Medication Adherence in People With Depressive Disorders

NCT03668457 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2023-04-12

No results posted yet for this study

Summary

Objective: The study of medication adherence in depression (MAPDep study) aims to evaluate the effectiveness and cost-effectiveness of a multi-component strategy to enhance patient-centered care to improve adherence toward medications in patients with depression, formed by an educational intervention to psychiatrists and/or a collaborative care intervention group to patients and relatives plus a reminder system through the use of a mobile APP.

Methods: The objective will be assessed under an open multicenter, clinical controlled trial with random allocation by clusters to one of three interventions or to usual care (control arm). In group 1 only patients and family members receive intervention, in group 2 only psychiatrists receive intervention, and group 3 is a combined intervention for patients and psychiatrists. The main measure will be the change in medication adherence rate. Secondary endpoints are depression, emotional distress, health-related quality of life, physical functioning, patients' knowledge about their medications, provider beliefs regarding patient-centeredness, and healthcare resource utilization.

Conditions

  • Depressive Disorder

Interventions

BEHAVIORAL

Intervention to Patients

Multifaceted intervention consisting of: 1. A collaborative care management intervention, including depression education, medication management and behavioral activation. 2. Use of a medication reminder mobile app.

BEHAVIORAL

Intervention to Psychiatrists

Educational intervention consisting of theoretical and practical sessions to to improve communication and negotiation abilities, and to develop skills to promote patient-centered care and shared decision-making.

OTHER

Control

Other: Usual care Usual care for depressive disorder received in mental health units

Sponsors & Collaborators

  • University of La Laguna

    collaborator OTHER
  • Servicio Canario de Salud

    lead OTHER

Principal Investigators

  • María del Mar Trujillo Martín, PhD · Servicio de Evaluación del Servicio Canario de la Salud

  • Carlos de las Cuevas Castresana, MD, PhD · University of La Laguna

  • Tasmania del Pino-Sedeño, PhD · University of La Laguna

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2022-11-01
Completion
2022-11-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03668457 on ClinicalTrials.gov